Sepsis syndromes: understanding the role of innate and acquired immunity
- PMID: 11508871
- DOI: 10.1097/00024382-200116020-00001
Sepsis syndromes: understanding the role of innate and acquired immunity
Abstract
An intact innate and acquired immune response are essential for defeating systemic microbial infections. Recognition molecules, inflammatory cells, and the cytokines they produce are the principal means for host tissues to recognize invading microbes and to initiate intercellular communication between the innate and acquired immune systems. However, activation of host innate immunity may also occur in the absence of microbial recognition, through expression of internal "danger" signals produced by tissue ischemia and necrosis. When activation of the innate immune system is severe enough, the host response itself can propel the patient into a systemic inflammatory response syndrome (SIRS), or even multiple system organ failure (MSOF) and shock. Although most patients survive the initial SIRS insult, these patients remain at increased risk of developing secondary or opportunistic infections because of the frequent onset of a compensatory anti-inflammatory response syndrome (CARS). The initial activation of the innate immune response often leads to macrophage deactivation, T-cell anergy, and the rapid apoptotic loss of lymphoid tissues, which all contribute to the development of this CARS syndrome and its associated morbidity and mortality. Initial efforts to treat the septic patient with anticytokine therapies directed at the SIRS response have been disappointing, and therapeutic efforts to modify the immune response during sepsis syndromes will require a more thorough understanding of the innate and acquired immune responses and the increased apoptosis in the lymphoid tissue.
Similar articles
-
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis.Scand J Immunol. 2009 Jun;69(6):479-91. doi: 10.1111/j.1365-3083.2009.02255.x. Scand J Immunol. 2009. PMID: 19439008 Review.
-
Cytokine signaling--regulation of the immune response in normal and critically ill states.Crit Care Med. 2000 Apr;28(4 Suppl):N3-12. doi: 10.1097/00003246-200004001-00002. Crit Care Med. 2000. PMID: 10807312 Review.
-
Monocyte-related immunopathologies in trauma patients.Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):321-8. Arch Immunol Ther Exp (Warsz). 2005. PMID: 16088316 Review.
-
[Host immunosuppression in pathogenesis of sepsis and its clinical implication].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Mar;19(3):138-41. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007. PMID: 17376264 Chinese.
-
Influence of systemic inflammatory response syndrome on host resistance against bacterial infections.Crit Care Med. 2004 Sep;32(9):1879-85. doi: 10.1097/01.ccm.0000139606.34631.61. Crit Care Med. 2004. PMID: 15343016
Cited by
-
Emerging infection and sepsis biomarkers: will they change current therapies?Expert Rev Anti Infect Ther. 2016 Oct;14(10):929-41. doi: 10.1080/14787210.2016.1222272. Epub 2016 Aug 17. Expert Rev Anti Infect Ther. 2016. PMID: 27533847 Free PMC article. Review.
-
Overactivation of mitogen-activated protein kinase and suppression of mitofusin-2 expression are two independent events in high mobility group box 1 protein-mediated T cell immune dysfunction.J Interferon Cytokine Res. 2013 Sep;33(9):529-41. doi: 10.1089/jir.2012.0054. Epub 2013 May 22. J Interferon Cytokine Res. 2013. PMID: 23697559 Free PMC article.
-
Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response.Infect Immun. 2012 Jun;80(6):2026-34. doi: 10.1128/IAI.00239-12. Epub 2012 Mar 26. Infect Immun. 2012. PMID: 22451518 Free PMC article.
-
Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).Sci Rep. 2016 Jun 20;6:28006. doi: 10.1038/srep28006. Sci Rep. 2016. PMID: 27320175 Free PMC article.
-
Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.Clin Exp Immunol. 2010 Dec;162(3):568-77. doi: 10.1111/j.1365-2249.2010.04262.x. Epub 2010 Oct 21. Clin Exp Immunol. 2010. PMID: 20964639 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources